An expert has warned that diverting malaria resources and interrupting prevention programs could kill thousands.
Benjamin Pretorius is managing director of ERADA Technology Alliance, the South-African start-up behind a saliva-based rapid diagnostic test for malaria, and he nearly died from the mosquito-borne disease.
He is alarmed to see COVID-19 threatening to derail more than a decade’s worth of hard-won gains in the fight against malaria.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze